Cornea
43
6
8
22
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.7%
2 terminated out of 43 trials
91.7%
+5.1% vs benchmark
0%
0 trials in Phase 3/4
5%
1 of 22 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 22 completed trials
Clinical Trials (43)
Corneal Topography and High Order Aberrations in Regular Contraceptive Pills
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
Acute Ocular Effects of Cigarette Smoking
Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
OCT Vibrography for Biomechanical Properties of Tissues
Intranasal Neurostimulation in Ameliorating Symptoms of Neuropathic Corneal Pain
INTACS for Non Ectatic With High Cylinder
Assessment of Corneal Topography and Densitometry in Rheumatoid Patients
Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells
Accuracy of Corneal Astigmatism in Different Region Modes
Assessment of an Automated Optical Coherence Tomography and Camera : Effectiveness of Vision-700
Comparison of Oral Isotretinoin vs Ancomparison of Oral Isotretinoin vs Antibiotics on Corneal Thickness With AV
Euclid Phoenix Lens Design Trial 2
Euclid Phoenix Lens Design Trial
MicroPulse Transscleral Laser Therapy and Its Short-term Impact on Ocular Surface
Multifocal-toric IOL Compared to Multifocal IOL Combined With Limbal Relaxing Incisions for Correction of Moderate Astigmatism During Cataract Surgery
Influence of Silicone Hydrogel Contact Lens Neophyte Wear on Corneal Sensitivity
Analysis of Topographic Corneal Parameters
To Investigate Agreement Between the EM-3000 and the Predicate Device Noncon Robo Pachy (F&A) (CellChek XL)